CIK: 0001372218 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $542,281 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRCT | PROCEPT BIOROBOTICS CORP | 11,222,662 | $280,679 | 51.8% | $38.38 | -3.6% | COM | 74276L105 |
| — | INSTIL BIO INC | 8,478,790 | $145,072 | 26.8% | $25.08 | — | COM | 45783C101 |
| — | REATA PHARMACEUTICALS INC | 2,896,901 | $76,391 | 14.1% | $31.64 | — | CL A | 75615P103 |
| — | APOLLO ENDOSURGERY INC | 3,878,742 | $32,698 | 6.0% | $4.23 | — | COM | 03767D108 |
| QQQ | INVESCO QQQ TR | 18,704 | $7,441 | 1.4% | $301.60 | — | UNIT SER 1 | 46090E103 |